InterMune, Myriad, News Corp., XL Capital: US Equity Preview – BusinessWeek
By Dr. Matthew Watson
 RTT News | InterMune, Myriad, News Corp., XL Capital: US Equity Preview BusinessWeek May 5 (Bloomberg) -- Shares of the following companies may have unusual moves in US trading. Stock symbols are in parentheses. ... US HOT STOCKS: Intermune, Myriad Genetics Drop In Late TradingWall Street Journal Myriad Genetics Reports Financial Results for Fiscal 2010 Third QuarterMarketWatch (press release) Salt Lake's Myriad Genetics' shares decline on cuts in 2010 revenue forecastSalt Lake Tribune Reuters -Learning Markets -Benzinga all 38 news articles » |
Uncategorized
Comments Off on InterMune, Myriad, News Corp., XL Capital: US Equity Preview – BusinessWeek |
May 5th, 2010
This author published 5852 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research